No Data
No Data
Bohui Innovation (300318.SZ): Currently, the in vitro diagnosis business is mainly HPV testing products and trace element testing products
Gelonghui, May 15, 丨 Bohui Innovation (300318.SZ) was surveyed by specific subjects on May 14, 2024, on “Other than HPV and human trace elements, what is the sales status of other IVD products and spectrometers?” The company replied that the company's in vitro diagnostic business is currently mainly HPV testing products and trace element testing products.
Bohui Innovation (300318.SZ): Currently, sales of blood products account for a relatively high proportion of retail sales
Gelonghui, May 15, 丨 Bohui Innovation (300318.SZ) was surveyed by a specific target on May 14, 2024, on “What is the ratio of the company's blood products sales side, hospital side, and retail side? What is the ratio of dealers' sales to their own sales? What is the sales channel situation?” The company replied that the company's current sales of blood products account for a relatively high proportion of sales on the retail side, and the hospital side also has a certain percentage, and the sales method is mainly distribution. At present, the company's sales channels have covered major provinces across the country.
Bohui Innovation (300318.SZ): Currently, the yield rate of albumin and static acrylic remains at the average level of the industry
Gelonghui, May 15, 丨 Bohui Innovation (300318.SZ) was surveyed by specific subjects on May 14, 2024, on “The company's yield rate of albumin and hydroxypropyl?” The company replied that at present, the yield rate of albumin and hydroxypropyl remains at the average level of the industry.
Bohui Innovation (300318.SZ): The new process of static acrylic is undergoing amplification test research
Gelonghui, May 11 | Bohui Innovation (300318.SZ) said on the investor interactive platform that the company's new Jingbing process is undergoing scale-up testing and research, and that human coagulation factor VIII is preparing a production registration declaration.
Bohui Innovation (300318.SZ): No synthetic biotechnology-related business
Gelonghui, May 11 | Bohui Innovation (300318.SZ) said on the investor interactive platform that the company is currently not engaged in synthetic biological related business.
Bohui Innovation (300318.SZ): The increase in performance in the first quarter was mainly due to the increase in revenue and gross profit of the blood products business
Gelonghui, May 10 | Bohui Innovation (300318.SZ) said on the investor interactive platform that the company's first quarter performance growth was mainly due to the increase in revenue and gross profit of the blood products business. The company will continue to focus on its main business, implement established strategies, pay close attention to scientific management, and continuously improve profit levels.
No Data